Bayzed Health Group (HKG:2609) raised HK$467.8 million in net proceeds from its initial public offering in Hong Kong, according to a Friday after-market filing with the Hong Kong bourse.
The oncology-focused healthcare services provider offered 133,105,800 shares priced at HK$4.22 apiece, the lower end of the indicative price range of as high as HK$6.75.
The public offering of the deal was 25.92 times subscribed, resulting in a total of 16,238,400 shares offered under this component, following the reallocation of 2,927,400 shares from the international offering.
The international offering was 0.98 time subscribed, and the number of shares offered was reduced to 116,867,400 following the reallocation.
Bayzed Health will make its trading debut on the Hong Kong Stock Exchange on Monday, June 23, when the opening bell sounds at 9am.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。